For those who live with diabetes, the costs of essential medications, like insulin, shouldn’t add to their burden. That’s why Cigna will offer the Patient Assurance Program beginning in 2020. By working with pharmaceutical manufacturers for this program, we will assist customers with diabetes in participating plans to manage their costs for eligible insulin products.
The Patient Assurance Program will:
A full list of drugs eligible under the program will be announced later in 2019. It will include some insulin products on the market such as Humulin, Humalog, Novolin, Novolog, and Lantus.
Beginning in early 2020, Cigna Pharmacy clients may elect to enroll in the Patient Assurance Program upon renewal or plan start. Clients must also be upgraded to our new claims engine. Note: This program is not available to Medicare or Medicaid plans. Insured plan availability is also dependent upon state filing approvals.
The Patient Assurance Program is a blueprint for other therapeutic areas where customers may be exposed to higher out-of-pocket medication costs - which may affect adherence for some customers.2
Patient Assurance Program is a trademark of Express Scripts Strategic Development, Inc.
Product availability may vary by location and plan type and is subject to change. All group health insurance policies and health benefit plans contain exclusions and limitations. For costs and details of coverage, review your plan documents or contact a Cigna representative.
All Cigna products and service are provided exclusively by or through operating subsidiaries of Cigna Corporation, including Cigna Health and Life Insurance Company, (CHLIC), Cigna Behavioral Health, Inc., Cigna Health Management, Inc., Evernorth, Accredo Health Group, Inc., Express Scripts, Inc., ESI Mail Pharmacy Service, Inc., Express Scripts Pharmacy, Inc., Tel-Drug, Inc., Tel-Drug of Pennsylvania, L.L.C., Lynnfield Drug, Inc., and HMO or service company subsidiaries of Cigna Health Corporation. Policy forms: OK - HP-APP-1 et al., OR - HP-POL38 02-13, TN - HP-POL43/HC-CER1V1 et al. (CHLIC). The Cigna name, logo, and other Cigna marks are trademarks of Cigna Intellectual Property, Inc. "Express Scripts" is a trademark of Express Scripts Strategic Development, Inc. This newsletter is not intended for residents of New Mexico.
© 2021 Cigna. All rights reserved